Cargando…
Advancing chimeric antigen receptor T cell therapy with CRISPR/Cas9
The clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 (CRISPR/Cas9) system, an RNA-guided DNA targeting technology, is triggering a revolution in the field of biology. CRISPR/Cas9 has demonstrated great potential for genetic manipulation. In this review, we discu...
Autores principales: | Ren, Jiangtao, Zhao, Yangbing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Higher Education Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5563282/ https://www.ncbi.nlm.nih.gov/pubmed/28434148 http://dx.doi.org/10.1007/s13238-017-0410-x |
Ejemplares similares
-
Increasing the safety and efficacy of chimeric antigen receptor T cell therapy
por: Li, Hua, et al.
Publicado: (2017) -
Nanobody-based chimeric antigen receptor T cells designed by CRISPR/Cas9 technology for solid tumor immunotherapy
por: Mo, Fengzhen, et al.
Publicado: (2021) -
Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing
por: Zhang, Song, et al.
Publicado: (2021) -
Advances in CRISPR/Cas9
por: Zhu, Youmin
Publicado: (2022) -
CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells
por: Rupp, Levi J., et al.
Publicado: (2017)